Comparison of combined oral contraceptive Yasmin and Cyproteron compound on Hirsutism and androgens in women with a polycystic ovary syndrome
Latest Information Update: 14 Sep 2016
At a glance
- Drugs Drospirenone/ethinylestradiol (Primary) ; Ethinylestradiol/cyproterone
- Indications Hirsutism
- Focus Pharmacodynamics
- 15 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by Iranian Registry of Clinical Trials record.
- 19 Apr 2012 New trial record